Aclaris Therapeutics, Inc. (ACRS) Discusses Positive Interim Results From ATI-052 Phase 1a Trial and Potential Therapeutic Advantages Transcript — Neutral
ACRS Seeking Alpha — January 06, 2026Aclaris Therapeutics, Inc. (ACRS) Discusses Positive Interim Results From ATI-052 Phase 1a Trial and Potential Therapeutic Advantages Transcript
Toll Brothers Announces Final Opportunity to Own a Luxury Home at Fontaine by Toll Brothers in Lake Mary, Florida — Neutral
TOL GlobeNewsWire — January 06, 2026Only one home remains in this exclusive gated community in a serene setting LAKE MARY, Fla., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced the final opportunity to purchase a new home at Fontaine by Toll Brothers, an exclusive gated community in Lake Mary, Florida.
Korea Electric Power: Spotlight On Electricity Tariffs And Cash Distributions — Negative
KEP Seeking Alpha — January 06, 2026I maintain a "Buy" rating for Korea Electric Power after analyzing its outlook pertaining to earnings and dividends. KEP's future profitability should benefit from lower energy prices and a growing nuclear generation mix, despite stagnant utility rates for 1Q26. KEP's payout ratios are expected to increase, considering its reduced financial leverage and pressure on Korea's state-owned entities to distribute more cash.
Intuitive Machines remains a volatile, high-upside play; I've locked in gains but stay tepidly bullish at current levels. LUNR's acquisition of Lanteris expands its space platform ambitions but brings dilution and near-term balance sheet pressure. Despite capital needs and operational setbacks, I see expectations at rock bottom.
ROSEN, A TOP-RANKED LAW FIRM, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKYE — Neutral
SKYE GlobeNewsWire — January 06, 2026NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025, both dates inclusive (the “Class Period”), of the important January 16, 2026 lead plaintiff deadline.
Lilly in talks to buy Ventyx Biosciences in more than $1 billion deal, WSJ reports — Positive
VTYX Reuters — January 06, 2026Eli Lilly is in advanced talks to buy Ventyx Biosciences for over $1 billion, the Wall Street Journal reported on Tuesday, citing people familiar with the matter.
TechnipFMC plc (FTI) Presents at Goldman Sachs Energy, CleanTech & Utilities Conference Transcript — Neutral
FTI Seeking Alpha — January 06, 2026TechnipFMC plc (FTI) Presents at Goldman Sachs Energy, CleanTech & Utilities Conference Transcript
Taiwan Semiconductor: The Ultimate AI Infrastructure Play With A $358 Target And +18% Upside — Positive
TSM Seeking Alpha — January 06, 2026Taiwan Semiconductor Manufacturing Company Limited (TSM) is the premier AI infrastructure play, offering unmatched diversification and technology leadership as the world's dominant semiconductor foundry. Record 2024 results—$90 billion revenue, 59% gross margins, and 36% ROE—validate TSM's irreplaceable position in advanced chip manufacturing for Nvidia, AMD, and Apple. TSM's 2nm node and CoWoS packaging expansions are key growth catalysts for 2026–2027, driving consensus price targets 20% above current levels.
Gauzy Ltd. (GAUZ) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
GAUZ PRNewsWire — January 06, 2026LOS ANGELES, Jan. 6, 2026 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Gauzy Ltd. ("Gauzy" or the "Company") (NASDAQ: GAUZ).
As Canadian cannabis king Tilray Brands, Inc. (NASDAQ: TLRY) prepares to report its fiscal Q2 2026 results on Thursday, the company stands at a crossroads.
TLX Deadline: TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Ltd. Securities Fraud Lawsuit Filed by The Rosen Law Firm — Neutral
TLX PRNewsWire — January 06, 2026NEW YORK, Jan. 6, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February 21, 2025 and August 28, 2025, both dates inclusive (the "Class Period"), of the important January 9, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.
NEW YORK, Jan. 6, 2026 /PRNewswire/ -- Travelzoo® (NASDAQ: TZOO), the club for travel enthusiasts, announces three of many new Club Offers for Club Members in the U.S. Rigorously vetted and negotiated for us travel enthusiasts: $899—IRELAND ROAD TRIP WITH FLIGHTS, HOTELS & CARSix nights of highlights, from Kilkenny to Dublin. This Club Offer includes spring dates.
Eli Lilly is in advanced talks to acquire Ventyx Biosciences for more than $1 billion, according to people familiar with the matter — Positive
LLY VTYX WSJ — January 06, 2026The more-than-$1 billion deal could come imminently.
Rosen Law Firm Encourages New Era Energy & Digital, Inc. Investors to Inquire About Securities Class Action Investigation - NUAI — Neutral
NUAI PRNewsWire — January 06, 2026NEW YORK, Jan. 6, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of New Era Energy & Digital, Inc. (NASDAQ: NUAI) resulting from allegations that New Era Energy & Digital may have issued materially misleading business information to the investing public. So What: If you purchased New Era Energy & Digital securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Lumentum Holdings Inc (NASDAQ: LITE) experienced a significant Power Inflow alert, a key bullish indicator that is closely tracked by traders who value order flow analytics, specifically institutional and retail order flow data.
F.N.B. Corporation Schedules Fourth Quarter 2025 Earnings Report and Conference Call — Neutral
FNB PRNewsWire — January 06, 2026PITTSBURGH, Jan. 6, 2026 /PRNewswire/ -- F.N.B. Corporation (NYSE: FNB) announced today that it plans to issue financial results for the fourth quarter of 2025 after the market close on Tuesday, January 20, 2026.
ROSEN, A RANKED AND LEADING FIRM, Encourages Integer Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - ITGR — Neutral
ITGR GlobeNewsWire — January 06, 2026NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Integer Holdings Corporation (NYSE: ITGR) between July 25, 2024 and October 22, 2025, both dates inclusive (the “Class Period”), of the important February 9, 2026 lead plaintiff deadline.
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights — Neutral
ALVO GlobeNewsWire — January 06, 2026NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Alvotech (NASDAQ: ALVO) resulting from allegations that Alvotech may have issued materially misleading business information to the investing public.
2 Very Different Ways to Trade Tesla as January Earnings Approach — Positive
TSLA MarketBeat — January 06, 2026Automotive giant Tesla Inc. NASDAQ: TSLA is heading into its next earnings report at the end of January with momentum suddenly working against it. After finally hitting fresh all-time highs just before Christmas, the stock has since logged its longest run of red days in months and is now down more than 12%.
Centrus Awarded $900 Million to Expand Uranium Enrichment in Ohio — Neutral
LEU PRNewsWire — January 06, 2026Funding supports previously announced multi-billion dollar expansion at Centrus' enrichment facility in Ohio Expected to create thousands of American jobs as Centrus restores the country's ability to enrich uranium at large scale BETHESDA, Md., Jan. 6, 2026 /PRNewswire/ -- Centrus Energy (NYSE: LEU) announced today that it has been selected by the U.S. Department of Energy for a $900 million task order to expand its uranium enrichment facility in Piketon, Ohio, to include commercial-scale production of High-Assay, Low-Enriched Uranium (HALEU).